Evidence map›Paper›PMID 41527106›Full record

ArticleCardiovascular diabetology2026

Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China Health and Retirement Longitudinal Study (2011-2020).

Hurong Lai, Chao Deng, Caifeng Liao, Ruixue Tian, Kexin Liu, Zhangjun Luo, Ling He, Huaijun Tu, Jian Li

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hurong Lai *The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Chao Deng *The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Caifeng LiaoThe Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Ruixue TianThe Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Kexin LiuThe Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Zhangjun LuoThe Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Ling HeDepartment of Geriatrics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Huaijun TuDepartment of Geriatrics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Jian LiDepartment of Clinical Trial Research Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. ndefy03048@ncu.edu.cn.

Funding

Internal Funding Program of the Second Affiliated Hospital of Nanchang University 2023efyB01Key Research and Development Program of Jiangxi Provincial Department of Science and Technology 20223BBG71006National Natural Science Foundation of China 81760033
6 · The paper itself

Abstract

backgroundThe triglyceride-glucose (TyG) index, estimated glucose disposal rate (eGDR), and metabolic score for insulin resistance (METS-IR) are well-established surrogate indices of insulin resistance (IR). Although both IR and elevated basal metabolic rate (BMR) are recognized risk factors for cardiometabolic diseases, their joint effects on the risk of cardiometabolic multimorbidity (CMM) remain unclear. This study aimed to investigate the separate and combined associations of these IR surrogates and BMR with incident CMM.

methodsWe included 7204 eligible participants from the 2011-2020 survey waves of the China Health and Retirement Longitudinal Study (CHARLS). Participants were stratified by median values of IR surrogate indices and BMR. The associations with CMM were assessed using Kaplan-Meier curves, multivariable Cox regression, and restricted cubic splines (RCS). Predictive performance was evaluated using receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Mediation and interaction analyses were performed to explore potential underlying relationships.

resultsOver a median follow-up of 9 years, 1103 participants (15.31%) developed CMM. Compared to those with low IR and low BMR, participants with high levels of both exhibited the highest risk of CMM, with hazard ratios of 2.13 (95% CI 1.73-2.63) for TyG, 1.93 (95% CI 1.57-2.36) for eGDR, and 1.92 (95% CI 1.61-2.29) for METS-IR. These associations remained consistent in subgroup and sensitivity analyses. Adding IR indices and BMR to the baseline model significantly improved CMM prediction: TyG (AUC 0.759, NRI 0.371, IDI 0.017; all P < 0.001), eGDR (AUC 0.753, NRI 0.330, IDI 0.012; all P < 0.01), and METS-IR (AUC 0.747, NRI 0.170, IDI 0.004; all P < 0.01). Mediation analysis demonstrated that all IR indices significantly mediated the association between BMR and CMM, and a bidirectional mediation relationship was specifically observed between BMR and the TyG index. Notably, no significant additive or multiplicative interactions were detected.

conclusionIR surrogate indices and BMR independently and jointly predicted the risk of CMM, with IR pathways substantially mediating the effect of BMR. The combined assessment of these parameters may improve CMM risk stratification and guide primary prevention strategies.

Indexed as

Basal MetabolismBlood GlucoseCardiovascular DiseasesInsulin ResistanceMetabolic SyndromePrimary PreventionAgedBiomarkersCardiometabolic Risk FactorsChinaFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedBiomarkersBlood GlucoseBasal metabolic rateCardiometabolic multimorbidityCHARLSInsulin resistance

Identifiers

PMID41527106
PMCPMC12888234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.